Literature DB >> 4289293

Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. I. Radioautographic analysis of the circulating cells in mice undergoing pertussis-induced hyperleukocytosis.

S I Morse, S K Riester.   

Abstract

By the use of radioautographic techniques it was shown that the lymphocytosis induced by Bordetella pertussis in mice was not caused by an increased production of lymphocytes but was primarily due to the entry into the circulation of mature cells from tissue pools. The accompanying polymorphonuclear leukocytosis was due to both proliferation of myeloid elements and entry of mature cells from tissue reserves, with the former the predominant mechanism.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4289293      PMCID: PMC2138289          DOI: 10.1084/jem.125.3.401

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  CHROMOSOME INVESTIGATIONS ON LYMPHOCYTES FROM IRRADIATED PATIENTS: EFFECT OF TIME IN CULTURE.

Authors:  K E BUCKTON; M C PIKE
Journal:  Nature       Date:  1964-05-16       Impact factor: 49.962

2.  LYMPHOCYTE CONTENT AND PROLIFERATIVE CAPACITY OF SERIALLY TRANSPLANTED MOUSE BONE MARROW.

Authors:  G CUDKOWICZ; A C UPTON; G M SHEARER; W L HUGHES
Journal:  Nature       Date:  1964-01-11       Impact factor: 49.962

3.  Radioautographic studies of small lymphocytes in the thoracic duct of the rat.

Authors:  R W CAFFREY; W O RIEKE; N B EVERETT
Journal:  Acta Haematol       Date:  1962       Impact factor: 2.195

4.  On the age of human white cells in peripheral blood.

Authors:  J OTTESEN
Journal:  Acta Physiol Scand       Date:  1954-10-20

5.  Determination of lymphocyte turnover by continuous infusion of H3 thymidine.

Authors:  J R LITTLE; G BRECHER; T R BRADLEY; S ROSE
Journal:  Blood       Date:  1962-02       Impact factor: 22.113

  5 in total
  21 in total

1.  Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes: enhancement of antibody formation by using subcutaneous administration of adjuvant and antigen.

Authors:  A J Murgo; T J Athanassiades
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

Review 2.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

3.  Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  A Adler; S I Morse
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

4.  Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization.

Authors:  Y Sato; H Arai
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

Review 5.  Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis.

Authors:  J Munoz; R K Bergman
Journal:  Bacteriol Rev       Date:  1968-06

6.  An assay for adjuvanticity.

Authors:  D W Dresser
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

7.  Changes produced by pertussis antigen on the blood cells and lympho-haemapoietic tissues after early and late thymectomy or splenectomy.

Authors:  P K Kalpaktsoglou; E J Yunis; R A Good
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

8.  Specific secondary biological properties of purified rabbit immunoglobulin M and immunoglobulin G antibodies to Brucella abortus and Bordetella pertussis.

Authors:  M L Schulkind; M Herzberg; J B Robbins
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

9.  Asymptomatic simian immunodeficiency virus infection decreases blood CD4(+) T cells by accumulating recirculating lymphocytes in the lymphoid tissues.

Authors:  A R Schenkel; H Uno; C D Pauza
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.

Authors:  Y Sato; H Arai; K Suzuki
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.